MedPath

广西南宁百会药业集团有限公司

Ownership
-
Established
2000-09-28
Employees
-
Market Cap
-
Website
https://www.baihuiyaoye.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

232

NMPA:232

Drug Approvals

Rotundine Hydrochloride

Product Name
盐酸罗通定
Approval Number
国药准字H45020631
Approval Date
Oct 10, 2024
NMPA

Dried Aluminium Hydroxide

Product Name
氢氧化铝
Approval Number
国药准字H45020625
Approval Date
Oct 10, 2024
NMPA

Hydrotalcite

Product Name
铝碳酸镁
Approval Number
国药准字H10960260
Approval Date
Oct 10, 2024
NMPA

Bromelain

Product Name
菠萝蛋白酶
Approval Number
国药准字H45021406
Approval Date
Oct 10, 2024
NMPA

Vitamin U

Product Name
维生素 u
Approval Number
国药准字H45021073
Approval Date
Oct 10, 2024
NMPA

Stanozolol

Product Name
司坦唑醇
Approval Number
国药准字H45020627
Approval Date
Oct 10, 2024
NMPA

Rotundine

Product Name
罗通定
Approval Number
国药准字H45020629
Approval Date
Oct 10, 2024
NMPA

Vitamin UⅡ

Product Name
维生素 uⅱ
Approval Number
国药准字H45020999
Approval Date
Oct 10, 2024
NMPA

Stepholidine

Product Name
千金藤啶碱
Approval Number
国药准字H45021572
Approval Date
Oct 10, 2024
NMPA

Furazalon

Product Name
呋咱甲氢龙
Approval Number
国药准字H45021079
Approval Date
Oct 10, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 24
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.